Harrow Health Inc (NASDAQ:HROW)
| 5.86 Delayed Data As of Sep 25 |  +0.32 / +5.78%Today’s Change | 3.33 Today|||52-Week Range 7.92 | -24.68% Year-to-Date |
Latest HROW News | Press Releases
| Harrow Health Inc (HROW) Investor Presentation - Slideshow Sep 18 / Seeking Alpha - Paid Partner Content | Our Take On Eton Pharmaceuticals Sep 01 / Seeking Alpha - Paid Partner Content |
| Harrow Health's Shares March Higher, Can It Continue? Sep 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.54 |
| Today’s open | 5.68 |
| Day’s range | 5.54 - 5.73 |
| Volume | 6,998 |
| Average volume (3 months) | 185,117 |
| Market cap | $150.6M |
Data as of 3:59pm ET, 09/25/2020
Growth & Valuation
| Earnings growth (last year) | -99.01% |
| Earnings growth (this year) | -370.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +23.67% |
| P/E ratio | NM |
| Price/Sales | 4.02 |
| Price/Book | 5.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVEOAveo Pharmaceuticals... | +0.22 | +3.89% |
| SESNSesen Bio Inc | +0.07 | +5.69% |
| SLNOSoleno Therapeutics ... | +0.04 | +2.21% |
| CRHMCRH Medical Corp | -0.05 | -2.36% |
Data as of 3:59pm ET, 09/25/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $51.2M |
| Annual profit (last year) | $168.0K |
| Net profit margin | 0.33% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
